Atrin Pharmaceuticals is a private biopharmaceutical company pioneering the discovery & development of proprietary molecules targeting DNA Damage and Response (DDR) pathways to treat a broad spectrum of cancers associated with synthetic lethality and the deregulated DNA Damage Response. 



Biotechnology

Pharmaceutical

Therapeutics

Atrin Pharmaceuticals

Oren Gilad

Molly Hansbarger

Dansu Li

Michel Afargan

Zeev Weiss

The Leadership Team at Atrin Pharmaceuticals drives the strategic vision and operational direction of the company. Composed of key executives including the President & CEO and the Chief Business Officers, this team is responsible for fostering innovation in drug development initiatives, overseeing business development efforts, and ensuring alignment with Atrin's mission to advance treatments targeting DNA Damage and Response pathways in cancer therapy.

Leadership Team

Directors Team

Advisory Team

Leadership Team

About

Team members

Other teams at Atrin Pharmaceuticals

Directors Team

Advisory Team